BDX Earnings Watch: Revenue Expected Flat, EPS Estimate $2.81PS

Becton, Dickinson and Company (NYSE:BDX) will report results Monday before the bell. Last quarter, the medical technology company posted revenue of $5.89 billion, up 8.3% year-on-year, and narrowly beat EPS estimates despite revenue in line with expectations. This quarter, analysts expect revenue to be flat year-on-year at $5.15 billion, down from a 9.8% increase in the same quarter last year, with adjusted earnings at $2.81 per share. Over the past 30 days, analyst estimates have remained stable, though the company has missed revenue guidance four times in the past two years. In the healthcare equipment and supplies sector, STERIS and CONMED posted revenue gains of 9.2% and 7.9%, respectively, outperforming estimates. STERIS shares fell 7.7% and CONMED 3.6% on results. BDX is up 3.6% over the last month, trading at $206.89 with an average analyst price target of $211.92.